Point of Care and Rapid Diagnostics Market projected to Reach USD 72.0 billion by 2027

Category: Health

The global Point of Care Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 Key Players - Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Quidel Corporation (US). Other leading players are Becton, Dickinson, and Company (US), Biomeriux S.A. (France), and Chembio Diagnostics (US)